Lupin launches generic equivalent of Northera capsules in US Ruchika Sharma29 Sept 2021 1:00 PM ISTMumbai: Global pharma major Lupin Limited has recently announced the launch of Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, having received...
Submit detailed rationale for developing Pantoprazole modified dosage form: CDSCO panel tells Lupin Medical Dialogues Team28 Sept 2021 6:01 PM ISTNew Delhi: In response to drug-maker Lupin's proposal of manufacturing and marketing Pantoprazole enteric coated delayed release tablets 40 mg...
Lupin to pay Rs 1824 crore to settle diabetes drug Glumetza suit in US Medical Dialogues Team23 Sept 2021 3:41 PM ISTNew Delhi: In an out-of-court settlement, Indian generic drug maker Lupin Pharmaceuticals Inc has decided to pay the Direct Purchaser Group Rs 1,103...
Lupin Goa facility gets 7 USFDA observations Ruchika Sharma20 Sept 2021 12:41 PM ISTMumbai: Global Pharma major, Lupin, has recently announced that the United States Food and Drug Administration (USFDA) has concluded an inspection...
Lupin unveils generic Duexis tablets in US Ruchika Sharma16 Sept 2021 11:31 AM ISTMumbai: Global pharma major, Lupin Limited, has recently announced the launch of the authorized generic version of Duexis (ibuprofen and famotidine)...
Lupin, TB Alliance parnter for anti-TB drug Pretomanid Ruchika Sharma7 Sept 2021 12:03 PM ISTMumbai: Non-profit drug developer, TB Alliance has recently granted global pharma major Lupin Limited, a non-exclusive license to manufacture the...
NPPA fixes retail price of 19 formulations including Metformin, Dapagliflozin, Details Medical Dialogues Team27 Aug 2021 1:45 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Lupin launches asthma, COPD drug Luforbec in UK Ruchika Sharma24 Aug 2021 5:13 PM ISTLuforbec is first branded generic alternative to Fostair 100/6 g pMDI for treatment of Asthma and COPD.
Lupin gets USFDA nod for partial-onset seizures drug Brivaracetam Ruchika Sharma17 Aug 2021 11:24 AM ISTMumbai: Global pharma major, Lupin Limited, has recently announced that the company has received tentative approval from the United States Food and...
NPPA approves prices of 25 new drugs including Dapagliflozin, Metformin, Details Medical Dialogues Team7 Aug 2021 4:48 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) approved retail pricing for 25 new drugs under the Drug Price Control Order...
Revise clinical trial protocol for Remdesivir powder for inhalation: CDSCO panel tells Lupin Medical Dialogues Team4 Aug 2021 4:00 PM ISTNew Delhi: In response to the drug maker Lupin's proposal to conduct a PhaseII/III Clinical Trial protocol for Remdesivir Powder for Inhalation,...
Lupin acquires Southern Cross Pharma in Australia Medical Dialogues Bureau31 July 2021 1:21 PM ISTLupin said as a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 million...
